INVACARE CORP (IVC) Fundamental Analysis & Valuation
NYSE:IVC • US4612031017
Current stock price
0.6598 USD
-0.02 (-2.25%)
At close:
0.53 USD
-0.13 (-19.67%)
Pre-Market:
This IVC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IVC Profitability Analysis
1.1 Basic Checks
- In the past year IVC has reported negative net income.
- In the past year IVC has reported a negative cash flow from operations.
1.2 Ratios
- IVC has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IVC's Gross Margin of 24.21% is on the low side compared to the rest of the industry. IVC is outperformed by 77.78% of its industry peers.
- IVC's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for IVC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.24%
2. IVC Health Analysis
2.1 Basic Checks
- IVC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for IVC has been increased compared to 1 year ago.
- IVC has a worse debt/assets ratio than last year.
2.2 Solvency
- IVC has an Altman-Z score of 0.90. This is a bad value and indicates that IVC is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 0.90, IVC is in line with its industry, outperforming 47.22% of the companies in the same industry.
- A Debt/Equity ratio of 4.82 is on the high side and indicates that IVC has dependencies on debt financing.
- IVC's Debt to Equity ratio of 4.82 is on the low side compared to the rest of the industry. IVC is outperformed by 88.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.9 |
ROIC/WACCN/A
WACC5.71%
2.3 Liquidity
- A Current Ratio of 1.32 indicates that IVC should not have too much problems paying its short term obligations.
- IVC's Current ratio of 1.32 is on the low side compared to the rest of the industry. IVC is outperformed by 85.65% of its industry peers.
- A Quick Ratio of 0.78 indicates that IVC may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.78, IVC is doing worse than 87.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.78 |
3. IVC Growth Analysis
3.1 Past
- The earnings per share for IVC have decreased strongly by -137.21% in the last year.
- The Revenue has decreased by -9.61% in the past year.
- IVC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.59% yearly.
EPS 1Y (TTM)-137.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-666.67%
Revenue 1Y (TTM)-9.61%
Revenue growth 3Y-3.55%
Revenue growth 5Y-3.59%
Sales Q2Q%-23.99%
3.2 Future
- IVC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.14% yearly.
- IVC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.30% yearly.
EPS Next Y-309.94%
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue Next Year-16.76%
Revenue Next 2Y-8.92%
Revenue Next 3Y-0.3%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. IVC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for IVC. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
5. IVC Dividend Analysis
5.1 Amount
- IVC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IVC Fundamentals: All Metrics, Ratios and Statistics
0.6598
-0.02 (-2.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2022-11-07/amc
Earnings (Next)03-06 2023-03-06/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners8.6%
Ins Owner Change0%
Market Cap24.91M
Revenue(TTM)786.60M
Net Income(TTM)-78.56M
Analysts83.33
Price Target1.68 (154.62%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-90.87%
Min EPS beat(2)-135.57%
Max EPS beat(2)-46.16%
EPS beat(4)1
Avg EPS beat(4)19.93%
Min EPS beat(4)-135.57%
Max EPS beat(4)296.04%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.25%
Min Revenue beat(2)-14.37%
Max Revenue beat(2)-10.12%
Revenue beat(4)1
Avg Revenue beat(4)-7.59%
Min Revenue beat(4)-14.37%
Max Revenue beat(4)0.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-49.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-111.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.5%
Revenue NQ rev (1m)-1.36%
Revenue NQ rev (3m)-14.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.04
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS20.83
BVpS2.15
TBVpS-6.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.21% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.24%
F-Score3
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 41% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 0.9 |
F-Score3
WACC5.71%
ROIC/WACCN/A
Cap/Depr(3y)110.34%
Cap/Depr(5y)98.77%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-666.67%
EPS Next Y-309.94%
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.61%
Revenue growth 3Y-3.55%
Revenue growth 5Y-3.59%
Sales Q2Q%-23.99%
Revenue Next Year-16.76%
Revenue Next 2Y-8.92%
Revenue Next 3Y-0.3%
Revenue Next 5YN/A
EBIT growth 1Y-4083.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-562.49%
EBIT Next 3Y89.23%
EBIT Next 5Y54.07%
FCF growth 1Y-151.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-397.05%
OCF growth 3YN/A
OCF growth 5YN/A
INVACARE CORP / IVC Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for INVACARE CORP?
ChartMill assigns a fundamental rating of 2 / 10 to IVC.
What is the valuation status of INVACARE CORP (IVC) stock?
ChartMill assigns a valuation rating of 3 / 10 to INVACARE CORP (IVC). This can be considered as Overvalued.
Can you provide the profitability details for INVACARE CORP?
INVACARE CORP (IVC) has a profitability rating of 1 / 10.
Can you provide the dividend sustainability for IVC stock?
The dividend rating of INVACARE CORP (IVC) is 0 / 10 and the dividend payout ratio is 0%.